Orrick Advises Third Rock Ventures on Investment in CARGO Therapeutics
1 minute read | March.02.2023

The proceeds from the financing will be used to advance CARGO’s autologous CD22 CAR T-cell therapy candidate, CRG-022.
1 minute read | March.02.2023
The proceeds from the financing will be used to advance CARGO’s autologous CD22 CAR T-cell therapy candidate, CRG-022.
January.18.2023
Orrick advised SFJ on its acquisition of assets related to the drug Bentracimab from PhaseBio.
1 minute read | January.09.2023
1 minute read | December.28.2022
1 minute read | November.11.2022
November.03.2022
October.17.2022
September.01.2022
The investment marks the first time MY DR NOW has received external capital.
September.01.2022
After a long and complex prenotification phase before the European Commission, Orrick obtained an early unconditional clearance of the transaction.
August.03.2022
July.25.2022
July.08.2022
by Thora Johnson, Kyle Kessler, Michaela Frai and Alyssa Wolfington
8 minute read | May.09.2023
26 minute read | April.25.2023
This edition of Orrick’s life sciences publication series reviews key trends of venture investment in the life sciences industry during Q1 2023.
by Kelly Hagedorn and Anna O'Kelly
9 minute read | March.23.2023
by Thora Johnson, Kyle Kessler, Hannah Levin and Alyssa Wolfington
6 minute read | March.14.2023
16 minute read | February.14.2023
Venture Funding and Tech Trends in Mental Health
by Joseph Perkins and Stephen Thau
January.17.2023
Joseph Perkins and Stephen Thau explain how early-stage biotech startups can use DAOs to provide an alternative to traditional sources of capital.
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn
December.15.2022
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn
December.01.2022
How the right level of IP due diligence can help inform investment decisions in the life sciences arena.
November.30.2022
ESG factors are increasingly important in the life sciences. Managing ESG risks and opportunities can be an important source of long-term value.
November.15.2022
by Thora Johnson, Hannah Levin, Cameron Carr and Michaela Frai
October.25.2022
The last year has seen a multijurisdictional regulatory push for increased cybersecurity standards for medical devices. Here's what you need to know.
23 minute read | October.24.2022
2 minute read | February.09.2023
Hagit Muriel Elul joins our international arbitration practice in New York from Hughes Hubbard.
4 minute read | November.15.2022
November.07.2022
September.09.2022
August.08.2022
August.01.2022
May.31.2022
Congratulations to Orrick partner Gregg Griner on being recognized as a Go-To Lawyer for Healthcare and Life Sciences by Massachusetts Lawyers Weekly.
February.22.2022
January.03.2022
October.11.2021
Orrick welcomes Franklin Monsour, a former federal prosecutor and experienced white collar and regulatory adviser to the life sciences sector.
Thora Johnson, a partner in Orrick’s Cyber, Privacy & Data Innovation Group, will lead the session “It’s Not Research, It’s Quality Improvement,” at the Health Care Compliance Association (HCAA) Research Compliance Conference.
Thora Johnson, a partner in Orrick's Cyber, Privacy & Data Innovation Group, will leading two panels at the 31st Annual National Health Insurance Portability and Accountability Act (HIPAA) Summit.